Emerging Targeted Therapies in Breast Cancer: Expanding HER2-Low and TROP-2 Breakthroughs Require Pharmacist Knowledge and VigilanceBySophia Hull, PharmD Candidate,Irene Bugriyev, PharmD Candidate,Shane P. Desselle, RPh, PhDMarch 16th 2026ADCs are reshaping metastatic breast cancer and pharmacists' roles in treatment management.